期刊文献+

乳腺癌肝转移临床特点及外科治疗 被引量:4

Clinical characteristics and surgical treatment for breast cancer patients with liver metastases
原文传递
导出
摘要 肝脏转移是乳腺癌常见的远处转移方式之一,传统治疗方法效果欠佳,是重要的预后不良因素。局限性乳腺癌肝转移手术切除的远期效果较好,部分病人可获得长期存活。但尚缺乏大规模临床资料证据,须进一步规范手术适应证、手术方式选择和综合治疗方案等。经皮激光热疗和射频消融等介入治疗为乳腺癌肝转移病人提供了新的外科治疗选择,多适合较小的肝脏转移灶,其应用范围尚有局限性,亦缺乏相关的临床对照研究。乳腺癌肝转移(较大病灶和多发性病灶)的外科治疗正在积极探索中。外科治疗结合综合治疗有望进一步改善乳腺癌肝转移病人预后。 Liver is one of the common metastatic sites for breast cancer. Breast cancer patients with liver metastases (BCLM) are often insensitive to traditional therapy and have poor prognosis. Liver resection is generally adopted if the lesion is localized, which has made BCLM obtain a better outcome. However, it still need to be supported by more large-scale clinical data and evidence, especially for standard operation indication, method and combined modality therapy. Minimally invasive surgery, such as radio frequency ablation (RFA) and laser-induced interstitial thermotherapy (LITT), could provide extra options for BCLM with small tumors, but both have some clinical limitations and still need further clinical study to confirm the curative effects. Surgical treatments for BCLM with comparatively large or nmhiple tumors are still under exploration. Systemic treatment combined with proper surgical process can improve BCLM prognosis.
作者 姜军 柴凡
出处 《中国实用外科杂志》 CSCD 北大核心 2011年第11期1017-1019,共3页 Chinese Journal of Practical Surgery
关键词 乳腺癌 肝脏转移癌 breast caneer liver metastasis
  • 相关文献

参考文献18

  • 1Gerber B, Freund M, Reimer T. Recurrent breast cancer: treat- ment strategies for maintaining and prolonging good quality of life [J]. Dtsch Arztebl Int, 2010,107(6):85-91.
  • 2Bergenfeldt M, Jensen BV, Skjoldbye B, et al. Liver resection and local ablation of breast cancer liver metastasese-A systemat- ic review [J]. Eur J Surg Oncol, 2011, 37(7):549-557.
  • 3Eichbaum MH, Kaltwasser M, Bruckner T, et al. Hepatic metas- tases from breast cancer [J]. Updates Surg, 2010, 62 (3-4): 143-148.
  • 4张彦,杨涛,唐英,白玲,毛京宁,范雪,陈伟.乳腺癌肝转移的超声特点及穿刺活检的价值[J].中华医学超声杂志(电子版),2010,7(4):33-35. 被引量:5
  • 5Arena E, Ferrero S. Surgical treatment of liver metastases from breast cancer[J]. Minerva Chir, 2004,59(1):7-15.
  • 6Vlastos G ,Smith DL ,Singletary SE ,et al. Long-termsurvivalaf- ter an aggressive surgical approach in patients with breast can- cer hepatic metastases [J]. Ann Surg Oncol, 2004, 11(9): 869-874.
  • 7Sakamoto Y, Yamamoto J, Yoshimoto M, et al. Hepatic resection for metastatic breast cancer: prognostic analysis of 34 patients [J]. World J Surg, 2005, 29(4):524-527.
  • 8Adam R, Aloia T, Krissat J, et al. Is liver resection justified for patients with hepaticmetastases from breast cancer? [J]. Ann Surg, 2006, 244(6):897-907.
  • 9Maria A, Cassera, Chet W, et al. Surgical management of breast cancer liver metastases [ J ]. HPB, 2011, 4(13):272-278.
  • 10Adam R, Delvart V, Pascal G, et al. Rescue surgery for unre- sectable colorectal liver metastases downstaged by chemothera- py: a model to predict long-term survival [J]. Ann Surg, 2004, 240(4):644-657.

二级参考文献17

共引文献18

同被引文献37

  • 1李勇,张嵘,梁碧玲,元建鹏,叶瑞心,钟镜联.肝转移瘤的MRI类型及少见类型的特征[J].癌症,2006,25(2):212-216. 被引量:7
  • 2王佳玉,徐兵河,田丽军,王燕.乳腺癌肝转移的临床病程与预后分析[J].中华肿瘤杂志,2006,28(8):612-616. 被引量:12
  • 3Champion L, Brain E, Giraudet AL, et al. Breast cancer recurrence diagnosis suspected on tumor marker rising:value of whole-body 18FDG-PET/CT imaging and impact on patient management. Cancer, 2011, 117 : 1621-1629.
  • 4Radan L, Ben-Haim S, Bar-Shalom R, et al. The role of FDG- PET/CT in suspected recurrence of breast cancer. Cancer, 2006, 107 : 2545-2551.
  • 5Yap CS, Seltzer MA, Schiepers C, et al. Impact of whole-body 18F-FDG PET on staging and managing patients with breast cancer:the referring physician's perspective. J Nucl Med, 2001, 42 : 1334-1337.
  • 6Veit-Haibach P, Antoch G, Beyer T, et al. FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy. Br J Radiol, 2007, 80:508-515.
  • 7Haug AR, Schmidt GP, Klingenstein A, et al. F-18-fluoro-2- deoxyglucose positron emission tomography/computed tomography in the follow-up of breast cancer with elevated levels of tumor markers. J Comput Assist Tomogr, 2007, 31:629-634.
  • 8Grassetto G, Fornasiero A, Otello D, et al. 18F-FDG-PET/CT in patients with breast cancer and rising Ca 15-3 with negative conventional imaging: a multicentre study. Eur J Radiol, 2011, 80:828-833.
  • 9Aukema TS, Rutgers E J, Vogel WV, et al. The role of FDG PET / CT in patients with locoregional breast cancer re-currence: a comparison to conventional imaging techniques. Eur J Surg Oncol, 2010,36:387-392.
  • 10Veronesi U, De Cicco C, Galimberti VE, et al. A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases. Ann Oncol, 2007, 18:473-478.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部